Bcr-Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factors

British Journal of Haematology

Volumn 100, Issue 2, 1998, Pages 295-303

  Jonuleit, Tarja ^a   Peschel, Christian ^b   Schwab, Renate ^b   Van Der Kuip, Heiko ^b   Bucnounger, Elisabeth ^c   Fischer, Thomas ^b   Huber, Christoph ^b   Aulitzky, Walter E ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c CIBA GEIGY LTD   (Switzerland)

Author keywords

Autocrine; BCR ABL kinase; CML; Deprivation; Kinase inhibitor

Indexed keywords

ALPHA2B INTERFERON; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMATINIB; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CELL; CELL CYCLE; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

CELL CYCLE; CELL DIVISION; ENZYME INHIBITORS; FUSION PROTEINS, BCR-ABL; GROWTH SUBSTANCES; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES;

EID: 0031952303     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00564.x     Document Type: Article

References (35)

1. Afar, D.E., Goga, A., McLaughlin, J., Witte, O.N. & Sawyers, C.L. (1994) Differential complementation of Bcr-Abl point mutants with c-Myc. Science, 264, 424-426.
2. Albrecht, T., Schwab, R., Henkes. M., Peschel, C., Huber, C. & Aulitzky, W.E. (1996) Primary proliferating immature myeloid cells from CML patients are not résistent to induction of apoptosis by DNA damage and growth factor withdrawal. British Journal of Haematology, 95, 501-507.
3. Aman, M.J., Keller, U., Derigs, G., Mohamadzadeh, M., Huber, C. & Peschel, C. (1994) Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of interleukin-l receptor antagonist. Blood, 84, 4142-4150.
4. Amos, T.A., Lewis, J.L., Grand, F.H., Gooding, R.P., Goldman, J.M. & Gordon, M.Y. (1995) Apoptosis in chronic myloid leukaemia: normal responses by progenitor cells to growth factor deprivation, X-irradiation and glucocorticoids. British Journal of Haematology, 91,387-393.
5. Anderson, S.M. & MIadenovic. J. (1996) The BCR-ABL oncogene requires both kinase activity and src-homology 2 domain to induce cytokine secretion. Blood, 87, 238-244.
6. Bedi, A., Barber, J.P., Bedi, G.C., el Deiry, W.S., Sidransky, D., Vala, M.S., Akhtar, A.J., Hilton, J. & Jones, R.J. (1995) BCR-ABLmediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood, 86, 1148-1158.
7. Bedi, A., Zehnbauer, B.A., Barber. J.P.. Sharkis, S.J. & Jones, R.J. (1994) Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood, 83, 2038-2044.
8. Ben Neriah, Y, Daley, G.Q., Mes-Masson, A.M., Witte. O.N. & Baltimore, D. (1986) The chronic myelogenous leukemia-specific p210 protein is the product of the bcr-abl hybrid gene. Science, 233, 212-214.
9. Bhatia, R., McGlave. P.B. & Verfaillie. C.M. (1995) Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors: role of MIP-1 alpha. Journal of Clinical Investigation, 96, 931-939.
10. Broxmeyer, H.E., Bicknell, D.C., Cooper, S., Sledge, G., Jr, Williams, D.E., McGuire, W.A. & Coates, T.D. (1991) Qualitative functional deficiency of affinity-purified lactoferrin from neutrophils of patients with chronic myelogenous leukemia, and lactoferrin/Hferritin-cell interactions in a patient with lactoferrin deficiency with normal numbers of circulating leukocytes. Pathobiology. 59, 26-35.
11. Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Muller, M., Druker, B.J. & Lydon, N.B. (1996) Inhibition of the Abl proteintyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Research, 56, 100-104.
12. Carlo-Stella, C., Cazzola, M., Ganser, A., Bergamaschi, G., Pedrazzoli, P., Hoelzer, D. & Ascari, E. (1988) Synergistic antiproliferative effect of recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E and CFU-GM). Blood, 72, 1293-1299.
13. Cashman, J.D., Eaves, A.C. & Eaves, C.J. (1994) The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism. Blood, 84. 1534-1542.
14. Chung, S.W., Wong, P.M., Shen Ong, G., Ruscetti, S., Ishizaka, T. & Eaves, C.J. (1986) Production of granulocyte-macrophage colonystimulating factor by Abelson virus-induced tumorigenic mast cell lines. Blood. 68. 1074-1081.
15. Cook. W.D., Metcalf, D., Nicola, N.A., Burgess. A.W. & Walker, F. (1985) Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell, 41, 677-683.
16. Cortez, D., Kadlec, L. & Pendergast, A.M. (1995) Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Molecular and Cellular Biology. 15, 5531-5541.
17. Daley, G.Q. & Baltimore, D. (1988) Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proceedings of the National Academy of Sciences of the United States of America, 85, 9312-9316.
18. Despres, D., Goldschmitt, J., Aulitzky, W.E., Huber, C. & Peschel, C. (1995) Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors. Experimental Hematology, 23, 1431-1438.
19. Druker, B.J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G.M., Fanning. S.. Zimmermann, J. & Lydon, N.B. (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of BcrAbl positive cells. Nature Medicine, 2, 561-566.
20. Eaves, A.C., Cashman, J., Gaboury, L.A., Kalousek, O.K. & Eaves, C.J. (1988) Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proceedings of the National Academy of Sciences of the United States of America, 83, 5306-5310.
21. Eaves, C. & Eaves, A. (1994) Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro. Blood Cells, 20, 83-93.
22. Emanuel, P.D., Bates, L.J., Castleberry, RJ. & Zuckerman, K.S. (1991) Selective hypersensitivity to granulocyte-macrophage colonystimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood, 77, 925-929.
23. Geissler, K., Peschel. C., Niederwieser, D., Goldschmitt, J., HIadik. F., Fritz, A., Ohler, L., Bettelheim, P., Huber, C., Lechner, K., Höcker, P. & Kolbe, K. (1995) Effect of interleukin-3 pretreatment on granulocyte/macrophage colony-stimulating factor induced mobilization of circulating haemopoietic progenitor cells. British Journal of Ilaematologij, 91, 299-305.
24. Groffen, J., Stephenson, J.R., Heisterkamp, N., de Klein, A., Bartram, C.R. & Grosveld, G. (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell, 36, 93-99.
25. Hariharan, I.K., Adams, J.M. & Cory, S. (1988) bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. Oncogene Research, 3, 387-399.
26. Ilaria, R.L, Jr & Van Etten. R.A. (1995) The SH2 domain of P210BCR/ABL is not required for the transformation of hematopoietic factor-dependent cells. Blood, 86, 3897-3904.
27. Lajmanovich, A., Berthier, R., Schweitzer, A., Leger, J. & Hollard, D. (1993) Constitutive expression of GM-CSF mRNA by CML blast cells is correlated with endogenous megakaryocytic colony formation. Leukemia, 7, 1211-1218.
28. Nowell, P.C. & Hungerford, D.A. (1960) A minute chromosome in human chronic granulocytic leukemia. Science, 132,1497-1501.
29. Pendergast, A.M., Quilliam, L.A., Cripe, G.. Bassing. C.H., Dai, Z., Li, N., Rabun, K.M., Der, C.J., Schlessinger, J. & Gishizky. M.L. (1993) BCR-ABL-induced oncogenesis is mediated by direct interaction wih the SH2 domain of the GRB-2 adaptor protein. Cell, 75.175185.
30. Puil, L., uu, J., Gish, G., Mbamalu. G., Bowtell, D., Pelicci, P.G., Arlinghaus, R. & Pawson, T. (1994) Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO Journal. 13. 764-773.
31. Roberts, A.W. & Metcalf, D. (1995) Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood, 86, 1600-1605.
32. Rowley. J.D. (1973) A new consistent chromosomal abnormality in chronic granulocytic leukemia identified by quinacrine fluorescence and Giemsa staining. Nature. 243, 290-293.
33. Schwab, S., Peschel, C., Despres, D., Derigs, G., Fischer, T., Huber, C. & Aulitzky. W.E. (1995) Deficient cell cycle control in myeloid cells of patients with newly diagnosed chronic myeloid leukemia. Cijtokines and Molecular Therapy. 1, 281-288.
34. Sirard, C., Laneuville, P. & Dick. J.E. (1994) Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism. Blood. 83, 1575-1585.
35. Wetzler, M., Talpaz, M., Van Etten, R.A., Hirsh Ginsberg, C., Beran, M. & Kurzrock, R. (1993) Subcellular localization of Bcr, Abl and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. Journal of Clinical Investigation, 92. 1925-1939.